-
Share
23,919 Posts.
752
30/05/13
09:48
Share
Should bring our cash and cash equivalents up to $1M+ now as they reported
No risk of dilution this quarter as 'material transactions are in process that aren't reflected in the shareprice'
Around 3 quarters worth of capital and debt free - great place to be for a junior bio on the edge of becoming cash flow positive
Assuming Brazil and Taiwan both worth around $3M each, currently negotiating $6M worth of cashflow per year, with a cap of just $10M
Rerating opportunity ?
-